HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Dummer Selected Research

Proteins (Proteins, Gene)

4/2020Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect.
11/2011In melanoma, beta-catenin is a suppressor of invasion.
8/2009Small molecules and targeted therapies in distant metastatic disease.
2/2002Fibroblasts enhance the invasive capacity of melanoma cells in vitro.
12/2001Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
5/2001Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
7/2000Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Dummer Research Topics

Disease

62Melanoma (Melanoma, Malignant)
01/2022 - 01/2000
34Neoplasms (Cancer)
04/2020 - 03/2000
16Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2017 - 01/2000
9Mycosis Fungoides
11/2021 - 11/2000
9Basal Cell Carcinoma (Rodent Ulcer)
09/2020 - 11/2003
8Lymphoma (Lymphomas)
01/2021 - 09/2000
7Neoplasm Metastasis (Metastasis)
01/2022 - 01/2001
6Brain Neoplasms (Brain Tumor)
11/2020 - 06/2001
5Disease Progression
04/2020 - 01/2000
4Actinic Keratosis
01/2019 - 07/2004
3B-Cell Lymphoma (Lymphoma, B Cell)
10/2000 - 03/2000
2Cicatrix (Scar)
12/2020 - 02/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2019 - 01/2016
2Skin Neoplasms (Skin Cancer)
10/2017 - 04/2010
2Sarcoma (Soft Tissue Sarcoma)
01/2016 - 09/2012
2Bowen's Disease (Disease, Bowen)
01/2016 - 08/2004
2Kaposi Sarcoma (Kaposi's Sarcoma)
08/2012 - 01/2000
2Body Weight (Weight, Body)
02/2012 - 01/2000
2Vitiligo
04/2007 - 01/2001
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2001 - 10/2000
1Sarcoidosis (Schaumann Disease)
12/2020
1Cancer Pain
04/2020
1Neutropenia
04/2020
1Alopecia (Baldness)
04/2019
1Fibrosarcoma
04/2019
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
06/2018
1Spasm (Spasms)
11/2017

Drug/Important Bio-Agent (IBA)

11AntigensIBA
01/2015 - 03/2000
8CytokinesIBA
11/2016 - 06/2000
7Proteins (Proteins, Gene)FDA Link
04/2020 - 07/2000
7Dacarbazine (DIC)FDA LinkGeneric
10/2017 - 01/2000
6Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2019 - 03/2014
6InterferonsIBA
11/2017 - 01/2000
6Interferon-alpha (Interferon Alfa)IBA
06/2008 - 01/2000
5Monoclonal AntibodiesIBA
10/2019 - 03/2000
5Phosphotransferases (Kinase)IBA
10/2017 - 08/2011
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022 - 07/2002
4AntibodiesIBA
04/2020 - 10/2017
4binimetinibIBA
01/2020 - 07/2014
4ParaffinIBA
04/2019 - 01/2001
4VemurafenibIBA
10/2017 - 07/2012
4Imatinib Mesylate (Gleevec)FDA Link
06/2017 - 08/2009
4Bexarotene (LGD1069)FDA Link
09/2012 - 01/2004
4Temozolomide (Temodar)FDA LinkGeneric
02/2012 - 04/2004
3NivolumabIBA
01/2021 - 02/2017
3sonidegibIBA
09/2020 - 03/2018
3HhAntag691IBA
09/2020 - 11/2017
3Formaldehyde (Formol)FDA Link
04/2019 - 01/2001
3Messenger RNA (mRNA)IBA
10/2017 - 02/2001
3Transcription Factors (Transcription Factor)IBA
01/2017 - 02/2001
3DNA (Deoxyribonucleic Acid)IBA
08/2009 - 01/2001
3Biological ProductsIBA
08/2009 - 07/2000
3HLA-G Antigens (HLA G)IBA
07/2005 - 09/2001
3Interleukin-2 (IL2)IBA
07/2002 - 01/2000
2IpilimumabIBA
01/2022 - 10/2017
2Immune Checkpoint InhibitorsIBA
04/2020 - 01/2017
2Pharmaceutical PreparationsIBA
04/2020 - 01/2000
2Programmed Cell Death 1 ReceptorIBA
01/2020 - 01/2019
2pembrolizumabIBA
01/2019 - 10/2017
2Mitogen-Activated Protein KinasesIBA
03/2017 - 09/2012
2Biomarkers (Surrogate Marker)IBA
01/2017 - 08/2009
2Paclitaxel (Taxol)FDA LinkGeneric
11/2016 - 03/2010
2trametinibIBA
12/2015 - 03/2014
2Ficusin (Psoralen)IBA
09/2012 - 01/2004
2Imiquimod (Aldara)FDA LinkGeneric
08/2012 - 11/2003
21-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2008 - 08/2004
2ErbB Receptors (EGF Receptor)IBA
01/2008 - 01/2003
2RetinoidsIBA
08/2006 - 11/2000
2Photosensitizing Agents (Photosensitizers)IBA
08/2004 - 07/2004
2Complementary DNA (cDNA)IBA
02/2004 - 01/2001
2Monophenol Monooxygenase (Tyrosinase)IBA
04/2003 - 06/2001
2Interleukin-7 (Interleukin 7)IBA
11/2001 - 09/2001
2Interleukin-15 (Interleukin 15)IBA
11/2001 - 09/2001
2VaccinesIBA
06/2001 - 04/2000
2Interferon-gamma (Interferon, gamma)IBA
06/2001 - 06/2001
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2001 - 07/2000
2Interleukin-12 (IL 12)IBA
01/2001 - 08/2000
2Rituximab (Mabthera)FDA Link
10/2000 - 03/2000
1VorinostatFDA Link
11/2021
1mogamulizumabIBA
11/2021
1talimogene laherparepvecIBA
10/2021
1Infliximab (Remicade)FDA Link
01/2021
1Analgesics (Analgesic Drugs)IBA
04/2020
1Dipyrone (Metamizole)IBA
04/2020
1encorafenibIBA
04/2019
1resiquimodIBA
01/2019
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2017

Therapy/Procedure

42Therapeutics
11/2021 - 01/2000
11Immunotherapy
10/2021 - 04/2000
7Radiotherapy
01/2020 - 06/2002
7Drug Therapy (Chemotherapy)
11/2015 - 04/2004
3Lymph Node Excision (Lymph Node Dissection)
07/2011 - 01/2000
3Photochemotherapy (Photodynamic Therapy)
11/2008 - 07/2004
2Withholding Treatment
01/2020 - 08/2006
2Investigational Therapies (Experimental Therapy)
01/2017 - 12/2003
2Lasers (Laser)
04/2012 - 02/2004
2Phototherapy (Light Therapy)
04/2007 - 01/2007
2Aftercare (After-Treatment)
07/2004 - 02/2001
1Duration of Therapy
01/2019
1Retreatment
10/2017